Baird raised the firm’s price target on Intuitive Surgical (ISRG) to $707 from $690 and keeps an Outperform rating on the shares. The firm said they posted stellar Q4 results as their best in class growth should continue despits 2025 P&L headwinds.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical price target raised to $670 from $538 at Piper Sandler
- Intuitive Surgical price target raised to $675 from $575 at JPMorgan
- Intuitive Surgical price target raised to $711 from $640 at Citi
- ISRG Earnings: Intuitive Surgical Stock Drops Despite Q4 Beat
- Intuitive Surgical Reports Strong Q4 2024 Performance